Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$71,000 |
 |
AstrazenecaAZN |
$32,000 |
 |
Johnson & JohnsonJNJ |
-$230,000 |
 |
ModernaMRNA |
$16,000 |
 |
AbbVieABBV |
$88,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Marjorie Taylor Greene | Oct 15, 2025 | Buy | $1K - $15K |
| Lisa McClain | Sep 11, 2025 | Buy | $1K - $15K |
| Marjorie Taylor Greene | Aug 28, 2025 | Buy | $1K - $15K |
| Marjorie Taylor Greene | Aug 19, 2025 | Buy | $15K - $50K |
| Lisa McClain | Aug 4, 2025 | Sell | $1K - $15K |
| Scott Mr Franklin | Aug 4, 2025 | Buy | $1K - $15K |
| Lisa McClain | Jun 9, 2025 | Buy | $1K - $15K |
| Laurel Lee | May 8, 2025 | Sell | $1K - $15K |
| Scott Franklin | Mar 27, 2025 | Buy | $1K - $15K |
| Byron Donalds | Mar 20, 2025 | Sell | $1K - $15K |
| Michael McCaul | Nov 19, 2024 | Sell | $50K - $100K |
| Michael McCaul | Oct 31, 2024 | Buy | $15K - $50K |
| Valerie Hoyle | Oct 29, 2024 | Buy | $1K - $15K |
| Michael McCaul | May 29, 2024 | Buy | $15K - $50K |
| Michael McCaul | May 28, 2024 | Buy | $15K - $50K |
| Michael McCaul | May 6, 2024 | Buy | $15K - $50K |
| Michael McCaul Republican | Apr 24, 2024 | Buy | $50K - $100K |
| Michael McCaul Republican | Apr 24, 2024 | Buy | $50K - $100K |
| Michael McCaul Republican | Apr 23, 2024 | Buy | $50K - $100K |
| Michael McCaul Republican | Apr 23, 2024 | Buy | $100K - $250K |
| Rohit Khanna Democrat | Feb 9, 2024 | Sell | $50K - $100K |
FAQ - Congress Trading
Marjorie Taylor Greene purchased Novo Nordisk shares most recently on October 15, 2025.
Michael McCaul has bought the most NVO stock in the last 2 years, with an estimated value of $530,000.
Rohit Khanna has sold the most NVO stock in the last 2 years, with an estimated value of $75,000.
According to our estimates, the net value of trades by US politicians for Novo Nordisk in the last 2 years is positive, amounting to $450,000. This indicates that US politicians have reasons to believe that the stock is going to go up.
Over the last 2 years, insider transactions for Novo Nordisk have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
